Compare MLSS & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | RDI |
|---|---|---|
| Founded | 1989 | 1937 |
| Country | United States | United States |
| Employees | N/A | 2025 |
| Industry | Industrial Specialties | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.1M | 24.8M |
| IPO Year | 1996 | N/A |
| Metric | MLSS | RDI |
|---|---|---|
| Price | $0.28 | $1.17 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 996.3K | 22.1K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,973,982.00 | N/A |
| Revenue This Year | $12.64 | $16.25 |
| Revenue Next Year | $8.99 | $4.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.99 | N/A |
| 52 Week Low | $0.22 | $0.94 |
| 52 Week High | $1.11 | $1.65 |
| Indicator | MLSS | RDI |
|---|---|---|
| Relative Strength Index (RSI) | 47.90 | 59.86 |
| Support Level | $0.27 | $0.99 |
| Resistance Level | $0.30 | $1.31 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 38.04 | 88.47 |
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.